Elsevier

Gynecologic Oncology

Volume 130, Issue 3, September 2013, Pages 652-659
Gynecologic Oncology

Review
Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States

https://doi.org/10.1016/j.ygyno.2013.05.020Get rights and content

Highlights

  • Compared to Caucasian women, African American women have lower incidence of uterine cancer but almost twice the mortality rates.

  • Treatment outcome disparities are not explained fully by differences in comorbidities and access to care.

  • Further research is necessary to eliminate racial disparities in uterine cancer.

Abstract

Objective

The objective of this article is to comprehensively review the scientific literature and summarize the available data regarding the outcome disparities of African American women with uterine cancer.

Methods

Literature on disparities in uterine cancer was systematically reviewed using the PubMed search engine. Articles from 1992 to 2012 written in English were reviewed. Search terms included endometrial cancer, uterine cancer, racial disparities, and African American.

Results

Twenty-four original research articles with a total of 366,299 cases of endometrial cancer (337,597 Caucasian and 28,702 African American) were included. Compared to Caucasian women, African American women comprise 7% of new endometrial cancer cases, while accounting for approximately 14% of endometrial cancer deaths. They are diagnosed with later stage, higher-grade disease, and poorer prognostic histologic types compared to their Caucasian counterparts. They also suffer worse outcomes at every stage, grade, and for every histologic type. The cause of increased mortality is multifactorial. African American and white women have varying incidence of comorbid conditions, genetic susceptibility to malignancy, access to care and health coverage, and socioeconomic status; however, the most consistent contributors to incidence and mortality disparities are histology and socioeconomics. More robust genetic and molecular profile studies are in development to further explain histologic differences.

Conclusions

Current studies suggest that histologic and socioeconomic factors explain much of the disparity in endometrial cancer incidence and mortality between white and African American patients. Treatment factors likely contributed historically to differences in mortality; however, studies suggest most women now receive equal care. Molecular differences may be an important factor to explain the racial inequities. Coupled with a sustained commitment to increasing access to appropriate care, on-going research in biologic mechanisms underlying histopathologic differences will help address and reduce the number of African American women who disproportionately suffer and die from endometrial malignancy.

Introduction

African Americans fare worse than whites across a spectrum of diseases, including diabetes, heart disease, and various malignancies. Gynecologic cancers are not immune to this phenomenon [1]. Endometrial cancer exhibits particularly striking racial differences. Despite a 30% decreased incidence among African Americans, those who are diagnosed with endometrial cancer are 2.5 times more likely to die than their Caucasian counterparts [2]. Though the explanation for this is likely multi-factorial, histopathologic disparities, with aggressive subtypes more common in African Americans, and socioeconomic differences, causing decreased access to healthcare among minority patients, are often assigned the largest roles. Other studies have examined molecular and genetic alterations, increased prevalence of comorbidities, and inconsistencies in treatment patterns among different races in an attempt to explain the inequalities. The purpose of this review is to examine the current literature in order to identify clinical, biological, and socioeconomic areas where disparities exist and identify ways to address these inequalities. Forty-two studies were initially identified, and 24 were reviewed after exclusion of studies that did not specifically address the disparities between African Americans and Caucasians with endometrial cancer. The reviewed studies had a total of 366,299 cases of endometrial cancer (337,597 Caucasian and 28,702 African American) (Table 1).

Section snippets

Incidence

Though African American women have a 7% lower incidence rate of all cancers when compared to white women, their overall cancer-related death rate is 17% higher. This discrepancy is seen in a variety of cancers including breast cancer and colorectal cancer [3], [4]. In endometrial cancer, the disparity is considerably more pronounced. The incidence in African Americans is 30% lower and the mortality rate 80% higher when compared to whites [1]. Fig. 1 shows the trend in incidence and mortality of

Histopathologic factors and stage at presentation

Five population-based studies and one large single-institution study documented the racial disparity in endometrial cancer histology and stage at presentation (Table 2, Table 3) [6], [7], [9], [11], [12], [13]. Though only one of these studies was a prospective analysis [7], all utilized large sample populations and reported similar rates of each cancer subtype across ethnic groups. They showed that African American patients are less likely than Caucasians to present with endometrioid histology

Molecular and genetic factors

African American women present with more aggressive subtypes of endometrial cancer and at more advanced stage compared to Caucasians. The increased incidence of serous and clear cell tumors and sarcomas accounts, at least in part, for more disseminated disease at presentation. Endometrioid endometrial cancer has a distinct genetic profile when compared to type II endometrial cancers. Racial differences in molecular and genetic factors may explain the histologic and survival discrepancy.

Socioeconomic factors

Biologic factors do not solely explain the survival disparity seen in endometrial cancer, as African American death rates remain higher at every stage, type, and grade of disease [2]. African Americans are more likely than Caucasians to live in poverty and reside in underserved areas. They are less likely to receive higher education, to possess private health insurance, and to have regular primary healthcare. Studies have found no difference in time from bleeding onset to consultation or

Comorbid factors

African Americans have higher rates of obesity, hypertension, diabetes, and heart disease and have worse health outcomes compared to other races in the United States. Some have argued that these comorbidities could explain the disparities found in this population, especially as these conditions also serve as risk factors for endometrial cancer.

In the Multiethnic Cohort Study of 46,933 women, Setiawan et al. found that endometrial cancer was positively associated with later age at menopause,

Treatment factors

Treatment factors have been suggested as a reason for the mortality disparity among African American women with endometrial cancer. Recent studies have examined the rates of definitive surgery and appropriate treatment for various ethnic groups. In an analysis of data from the National Cancer Database from 1988 to 1994, Hicks et al. found that African American women were less likely to undergo definitive surgery at every stage of disease. Even for stage I disease, 7.7% of African American women

Conclusion and recommendations

The survival disparity in African American women with endometrial cancer is multifactorial, and its complexity highlights the need for continued research in this area. Despite having a lower incidence of endometrial cancer, African American women have almost twice the disease-specific mortality rate [38]. Our analysis suggests that histopathologic factors play the largest role in the disparity, with African Americans experiencing higher rates of aggressive histologic subtypes, poorly

Conflict of interest statement

The authors have no conflicts of interest or financial relationships to disclose.

References (43)

  • R.P. Matthews et al.

    Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women

    Gynecol Oncol

    (1997)
  • E.L. Trimble et al.

    Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States

    Gynecol Oncol

    (2005)
  • C.C. Gotay et al.

    Impact of a culturally appropriate intervention on breast and cervical screening among native Hawaiian women

    Prev Med

    (2000)
  • J. Farley et al.

    Racial disparities in blacks with gynecologic cancers

    Cancer

    (2007)
  • A. Jemal et al.

    Cancer statistics, 2010

    CA Cancer J Clin

    (2010)
  • D.D. Alexander et al.

    African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review

    Cancer Biomark

    (2007)
  • M.A. Gerend et al.

    Social determinants of Black–White disparities in breast cancer mortality: a review

    Cancer Epidemiol Biomarkers Prev

    (2008)
  • Centers for Disease Control and Prevention

    Uterine cancer rates by race and ethnicity

  • M.E. Sherman et al.

    Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus

    Cancer

    (2003)
  • V.W. Setiawan et al.

    Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study

    Am J Epidemiol

    (2007)
  • A. Jemal et al.

    Cancer statistics, 2008

    CA Cancer J Clin

    (2008)
  • Cited by (0)

    View full text